Jon Aning
Papers
5
Total Citations
446
H-Index
5
About
Jon Aning is a leading urological surgeon and researcher whose work centers on improving surgical outcomes for patients with bladder and prostate cancers. His major contributions lie in two pivotal areas: evaluating the benefits of robot-assisted surgery and preserving nerve function during prostatectomy. Aning was the lead author of a landmark 2022 study in *JAMA* comparing robot-assisted radical cystectomy with intracorporeal urinary diversion to open surgery, which found no significant difference in 90-day morbidity or mortality—a finding that has shaped clinical practice and garnered over 320 citations. He also spearheaded the NeuroSAFE PROOF trials, investigating a real-time frozen section technique to spare neurovascular bundles during robot-assisted radical prostatectomy. This work demonstrated that NeuroSAFE-guided surgery can improve erectile function and early urinary continence without compromising cancer control, with results published in a 2025 phase 3 trial. Additionally, Aning has contributed to health economics, showing that robot-assisted cystectomy may be cost-effective. His research, cited over 400 times, directly addresses the trade-offs between oncologic control and quality of life, making him a key voice in evidence-based surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5